Hydroxyurea Hydroxycarbamide
Hydroxyurea 通过抑制核糖核苷酸还原酶抑制 DNA 合成的细胞凋亡诱导剂。
-
货号:
TK0231 -
规格:
- 500mg
- 1g
- 5g
-
价格:
¥0.00
Hydroxyurea 通过抑制核糖核苷酸还原酶抑制 DNA 合成的细胞凋亡诱导剂。
| CAS No. | 127-07-1 |
| 生物活性 | Hydroxyurea is a cell apoptosis inducer that inhibit DNA synthesis through inhibition of ribonucleotide reductase. |
| 分子式 | CH4N2O2 |
| 分子量 | 76.05 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存条件 | Powder -20°C 3 years |
| 溶解性数据 | DMSO : 50 mg/mL (657.46 mM; Need ultrasonic) H2O : 50 mg/mL (657.46 mM; Need ultrasonic) |
| 体内研究 | Hydroxyurea therapy producs consistent reductions in WBC and ANC without improvement in anemia over 17 weeks. Hydroxyurea at 50mg/kg produces a reduced white blood cell count, absolute neutrophil count and no improvement in anemia compared to vehicle treated sickle cell mice. |
| 体外研究 | Hydroxyurea is used in a number of myeloproliferative, neoplastic, HIV, and non-hematological diseases. Treatment of cells in primary culture with 30 μM hydroxyurea for 96 hours significantly increases the fractional HbF content. The γ: γ-globin mRNA is induced 0.30- to 8-fold in vitro. Hydroxyurea has been shown to block HIV-1 reverse transcription and/or replication in quiescent peripheral blood mononuclear cells and macrophages. |
| 文献 | •Cell Death Dis. 2020 Nov 12;11(11):976. •Cell Death Dis. 2020 Jun 15;11(6):464. •J Cell Mol Med. 2019 Oct;23(10):6797-6804. •J Mol Med (Berl). 2019 Aug;97(8):1183-1193. •Arch Biochem Biophys. 2020 Nov 15;694:108601. |
| 纯度及产品资料 | 98% |